Per Artursson

Active 1984–2024

147
Papers
28,836
Citations
96
h-index
142
i10-index

Citations

Citations per year for Per Artursson1940: 1 citations1975: 1 citations1987: 1 citations1990: 3 citations1991: 12 citations1992: 16 citations1993: 45 citations1994: 23 citations1995: 54 citations1996: 91 citations1997: 110 citations1998: 159 citations1999: 174 citations2000: 191 citations2001: 252 citations2002: 262 citations2003: 274 citations2004: 274 citations2005: 272 citations2006: 271 citations2007: 270 citations2008: 280 citations2009: 309 citations2010: 280 citations2011: 283 citations2012: 316 citations2013: 306 citations2014: 292 citations2015: 256 citations2016: 331 citations2017: 298 citations2018: 269 citations2019: 816 citations2020: 879 citations2021: 804 citations2022: 567 citations2023: 418 citations2024: 572 citations2025: 243 citations2026: 14 citations1941–1974: no citations, so these years are not shown1976–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,901 citing papers, 20% of this breakdownChina: 925 citing papers, 9.7% of this breakdownUnited Kingdom: 659 citing papers, 6.9% of this breakdownGermany: 624 citing papers, 6.6% of this breakdownSweden: 508 citing papers, 5.3% of this breakdownIndia: 343 citing papers, 3.6% of this breakdownJapan: 304 citing papers, 3.2% of this breakdownItaly: 274 citing papers, 2.9% of this breakdownSwitzerland: 264 citing papers, 2.8% of this breakdownFrance: 258 citing papers, 2.7% of this breakdownCanada: 247 citing papers, 2.6% of this breakdownNetherlands: 247 citing papers, 2.6% of this breakdown
0%20%Other 31.1%

Fields

  • Medicine28.3%
  • Biochemistry, Genetics and Molecular Biology21%
  • Pharmacology, Toxicology and Pharmaceutics19.9%
  • Computer Science8.8%
  • Materials Science4.6%
  • Chemistry3.5%
  • Other13.9%

Topics

  • Drug Transport and Resistance Mechanisms6.9%
  • Advanced Drug Delivery Systems6.6%
  • Computational Drug Discovery Methods4.8%
  • Drug Solubulity and Delivery Systems4.4%
  • RNA Interference and Gene Delivery3.1%
  • Pharmacogenetics and Drug Metabolism2.5%
  • Other71.7%

Coauthors

All papers

Open in search
  1. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers

    Authors: , , - Nature Protocols 2007 cited by 1,458

  2. Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues

    Authors: , - Advanced Drug Delivery Reviews 2016 cited by 476

  3. Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

    Authors: , , - Advanced Drug Delivery Reviews 2001 cited by 1,534

  4. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells

    Authors: , - Biochemical and Biophysical Research Communications 1991 cited by 1,868

  5. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mikael Altun, Fabienne Z. Gaugaz, Svante Vikingsson, Bastiaan Evers, Martin Henriksson, Karl S. A. Vallin, Olov Wallner, Lars G.J. Hammarström, Elisée Wiita, Ingrid Almlöf, Christina Kalderén, Hanna Axelsson, Tatjana Djureinovic, Jordi Carreras‐Puigvert, Maria Häggblad, Fredrik Jeppsson, Ulf Märtens, Cecilia Lundin, Bo Lundgren, Ingrid Granelli, Annika Jenmalm Jensen, Per Artursson, Jonas A. Nilsson, Pål Stenmark, Martin Scobie, Ulrika Warpman Berglund, Thomas Helleday - Nature 2014 cited by 529

  6. Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paweł Baranczewski, Per Artursson, Mikael Altun, Annika Jenmalm Jensen, Christina Kalderén, Xueqing Ba, Roman A. Zubarev, Pål Stenmark, István Boldogh, Thomas Helleday - Science 2018 cited by 233

  7. Coexistence of passive and carrier-mediated processes in drug transport

    Authors: , , , , , , , , , , , - Nature Reviews Drug Discovery 2010 cited by 653

  8. Structural and conformational determinants of macrocycle cell permeability

    Authors: , , , , , , , , , , , , , , , - Nature Chemical Biology 2016 cited by 213

  9. Polar Molecular Surface Properties Predict the Intestinal Absorption of Drugs in Humans

    Authors: , , , - Pharmaceutical Research 1997 cited by 751

  10. The Critical Role of Passive Permeability in Designing Successful Drugs

    Authors: , , , , , , , , , - ChemMedChem 2020 cited by 109

  11. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes

    Authors: , , , - Journal of Proteomics 2016 cited by 184

  12. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elena Toader, Kateřina Valentová, Maria Vertzoni, Saskia N. de Wildt, Clive Wilson, Patrick Augustijns - Advanced Drug Delivery Reviews 2021 cited by 145

  13. Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines

    Authors: , , , , , - Drug Metabolism and Disposition 2007 cited by 580

  14. Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

    Authors: , , , , , , , - Journal of Medicinal Chemistry 2012 cited by 365

  15. CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil

    Authors: , , , , , , , , , , - Nature Communications 2016 cited by 164

  16. Global variability analysis of mRNA and protein concentrations across and within human tissues

    Authors: , , , , , , , , - NAR Genomics and Bioinformatics 2019 cited by 103

  17. Hepatocyte size fractionation allows dissection of human liver zonation

    Authors: , , , , , , , , , , - Journal of Cellular Physiology 2021 cited by 24

  18. Regional levels of drug transporters along the human intestinal tract: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells

    Authors: , , , , , , , - European Journal of Pharmaceutical Sciences 2006 cited by 368

  19. Absorption Enhancement through Intracellular Regulation of Tight Junction Permeability by Medium Chain Fatty Acids in Caco-2 Cells

    Authors: , , - Journal of Pharmacology and Experimental Therapeutics 1998 cited by 327

  20. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.

    Authors: , , - Journal of Pharmacology and Experimental Therapeutics 1995 cited by 194

  21. Validation and development of MTH1 inhibitors for treatment of cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evert Homan, Elisée Wiita, Varun Nagpal, Thomas Meijer, Nicolaas Schipper, Sean G. Rudd, Lars Bräutigam, Annika Lindqvist, Anne M. Filppula, Te‐Chang Lee, Per Artursson, Jonas A. Nilsson, Vassilis G. Gorgoulis, Janne Lehtiö, Roman A. Zubarev, Martin Scobie, Thomas Helleday - Annals of Oncology 2016 cited by 145

  22. Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity

    Authors: , , , , , , , , , - Clinical Pharmacology & Therapeutics 2022 cited by 41

  23. Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)

    Authors: , , , - Pharmaceutical Research 1994 cited by 770

  24. Transport of Lipophilic Drug Molecules in a New Mucus-Secreting Cell Culture Model Based on HT29-MTX Cells

    Authors: , , , - Pharmaceutical Research 2001 cited by 219